Filing Details
- Accession Number:
- 0001140361-13-023930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-04 16:21:20
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-06-04
- Accepted Time:
- 2013-06-04 16:21:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380187 | Daniel Abdun-Nabi | 2273 Research Blvd. Suite 400 Rockville MD 20850 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-31 | 800 | $12.07 | 96,011 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Consists of shares acquired under the Emergent BioSolutions Employee Stock Purchase Plan on May 31, 2013.
Billionaire Hedge Funds
